Gamco Investors INC. ET AL Reduces Holdings in STERIS plc (NYSE:STE)

Gamco Investors INC. ET AL cut its position in STERIS plc (NYSE:STE) by 0.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 84,350 shares of the medical equipment provider’s stock after selling 800 shares during the quarter. Gamco Investors INC. ET AL owned 0.09% of STERIS worth $17,339,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Magnolia Capital Advisors LLC boosted its position in STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after buying an additional 48 shares during the last quarter. SkyView Investment Advisors LLC increased its holdings in STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after purchasing an additional 51 shares during the last quarter. Park Edge Advisors LLC increased its holdings in STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after purchasing an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI raised its position in shares of STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after purchasing an additional 54 shares in the last quarter. Finally, Opal Wealth Advisors LLC grew its position in shares of STERIS by 5.7% during the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock worth $230,000 after buying an additional 60 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

STE has been the topic of several recent analyst reports. Stephens reaffirmed an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, April 10th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Stock Performance

Shares of NYSE STE opened at $221.17 on Wednesday. The stock has a market capitalization of $21.73 billion, a P/E ratio of 46.96 and a beta of 0.87. The firm’s 50-day moving average price is $222.59 and its two-hundred day moving average price is $219.41. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date was Thursday, February 20th. STERIS’s payout ratio is 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.